When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KALTF - Kalytera says prodrug R-107 provides sustained release of nitric oxide in preclinical models
Kalytera Therapeutics
Kalytera Therapeutics (OTC:KALTF+70.3%) says R-107 readily converts in vivo into its active payload R-100, which accumulates and provides for a sustained release of nitric oxide into lung tissues.
More news on: Kalytera Therapeutics Inc., Healthcare stocks news,